Beneficial ownership — 13D / 13G
85,706 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | EYE National Vision Holdings, Inc. | 13G/A | 12.6% | Dec 31, 2023 | 2y |
| Sakellaris George P | AMRC Ameresco, Inc. | 13G/A | 39.5% | Dec 31, 2023 | 2y |
| American Century Investment Management, Inc. | FBP First Bancorp | 13G/A | 4.8% | Dec 31, 2023 | 2y |
| BASSWOOD CAPITAL MANAGEMENT, L.L.C. | ESQ Esquire Financial Holdings, Inc. | 13G/A | 4.78% | Dec 31, 2023 | 2y |
| Topline Capital Management, LLC | IDN Intellicheck, Inc. | 13G/A | 6.6% | Dec 31, 2023 | 2y |
| PRIMECAP MANAGEMENT CO/CA/ | FLEX Flex Ltd. | 13G/A | 10.42% | Dec 31, 2023 | 2y |
| NEUBERGER BERMAN GROUP LLC | STVN Stevanato Group S.p.A. | 13G | 9.93% | Dec 31, 2023 | 2y |
| BIOGEN INC. | DNLI Denali Therapeutics Inc. | 13G/A | 1% | Dec 31, 2023 | 2y |
| EARNEST PARTNERS LLC | AIN Albany International Corp | 13G/A | 8.1% | Dec 31, 2023 | 2y |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | NUE Nucor Corp | 13G/A | 8.1% | Dec 31, 2023 | 2y |
| Mei Mei Hu | VAXX Vaxxinity, Inc. Class A Common Stock | 13G/A | 70.5% | Dec 31, 2023 | 2y |
| BRANDES INVESTMENT PARTNERS, LP | EGRX Eagle Pharmaceuticals, Inc. | 13G | 5.74% | Dec 31, 2023 | 2y |
| GQG Partners LLC | APP AppLovin Corp | 13G | 9.71% | Dec 31, 2023 | 2y |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | MTRX Matrix Service Co | 13G/A | 8% | Dec 31, 2023 | 2y |
| RWWM, Inc. | DJCO Daily Journal Corp | 13G/A | 23.53% | Dec 31, 2023 | 2y |
| JANUS HENDERSON GROUP PLC | ETNB 89bio, Inc. Common Stock | 13G/A | 9.6% | Dec 31, 2023 | 2y |
| Carlyle Group Inc. | GTM ZoomInfo Technologies Inc. | 13G/A | 9% | Dec 31, 2023 | 2y |
| LeMaitre George W | LMAT Lemaitre Vascular Inc | 13G/A | 10.3% | Dec 31, 2023 | 2y |
| LMR Partners LLP | IXAQF IX Acquisition Corp. | 13G/A | 1.3% | Dec 31, 2023 | 2y |
| MORGAN STANLEY | BCAT BlackRock Capital Allocation Term Trust | 13G/A | 5.7% | Dec 31, 2023 | 2y |
| American Century Investment Management, Inc. | KLIC Kulicke & Soffa Industries Inc | 13G/A | 5.4% | Dec 31, 2023 | 2y |
| Polar Asset Management Partners Inc. | FRLA Fortune Rise Acquisition Corporation Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Topline Capital Management, LLC | OPXS Optex Systems Holdings Inc | 13G/A | 11.8% | Dec 31, 2023 | 2y |
| Charles Gillespie | GRSD GRANDSTAND Ltd | 13G/A | 13.5% | Dec 31, 2023 | 2y |
| ARISTEIA CAPITAL, L.L.C. | TGAA Target Global Acquisition I Corp. Class A Ordinary Share | 13G/A | 0% | Dec 31, 2023 | 2y |
| Durable Capital Partners LP | DUOL Duolingo, Inc. | 13G/A | 8.9% | Dec 31, 2023 | 2y |
| Contrarius Investment Management Ltd | WW Ww International, Inc. | 13G | 9.4% | Dec 31, 2023 | 2y |
| ARISTEIA CAPITAL, L.L.C. | HCVI Hennessy Capital Investment Corp. VI Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| DRIVEN EQUITY SUB LLC | DRVN Driven Brands Holdings Inc. | 13G/A | 42% | Dec 31, 2023 | 2y |
| FULLER & THALER ASSET MANAGEMENT, INC. | WTM White Mountains Insurance Group Ltd | 13G/A | 5.06% | Dec 31, 2023 | 2y |
| MORGAN STANLEY | ARQT Arcutis Biotherapeutics, Inc. | 13G | 6.5% | Dec 31, 2023 | 2y |
| JANUS HENDERSON GROUP PLC | MIR Mirion Technologies, Inc. | 13G/A | 4.3% | Dec 31, 2023 | 2y |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | BWXT BWX Technologies, Inc. | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| Howard Todd Horberg | EQS Equus Total Return, Inc. | 13G/A | 5.21% | Dec 31, 2023 | 2y |
| Taconic Capital Advisors LP | PRIAF Prime Impact Acquisition I | 13G/A | 0% | Dec 31, 2023 | 2y |
| Patrick G. Ryan | RYAN Ryan Specialty Holdings, Inc. | 13G/A | 55.32% | Dec 31, 2023 | 2y |
| Polar Asset Management Partners Inc. | VEEA Veea Inc. | 13G/A | 2.7% | Dec 31, 2023 | 2y |
| Pathfinder Bank Employee Stock Ownership Plan Trust | PBHC Pathfinder Bancorp, Inc. | 13G/A | 6.2% | Dec 31, 2023 | 2y |
| Altshuler Shaham Ltd | KEN Kenon Holdings Ltd. | 13G/A | 6.4% | Dec 31, 2023 | 2y |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | IVC Invacare Corporation | 13G/A | 0% | Dec 31, 2023 | 2y |
| FIFTHDELTA Ltd | INVZ Innoviz Technologies Ltd. | 13G/A | 5.29% | Dec 31, 2023 | 2y |
| MPM BioVentures 2018 LLC | DYN Dyne Therapeutics, Inc. | 13G/A | 4.3% | Dec 31, 2023 | 2y |
| Lou Reese | VAXX Vaxxinity, Inc. Class A Common Stock | 13G/A | 9.4% | Dec 31, 2023 | 2y |
| OR Cantor Fitzgerald Securities | PFTA Perception Capital Corp. III Class A Ordinary Share | 13G/A | 0% | Dec 31, 2023 | 2y |
| Rubric Capital Management LP | OVID Ovid Therapeutics Inc. | 13G/A | 7.52% | Dec 31, 2023 | 2y |
| American Century Investment Management, Inc. | BBSI Barrett Business Services Inc | 13G/A | 3.68% | Dec 31, 2023 | 2y |
| Bristol Investment Fund, Ltd. | RSSS Research Solutions, Inc. | 13D/A | 4.2% | Dec 31, 2023 | 2y |
| NEUBERGER BERMAN GROUP LLC | UFPT Ufp Technologies Inc | 13G/A | 9.96% | Dec 31, 2023 | 2y |
| JANE STREET GROUP, LLC | DGNU Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares | 13G/A | 0% | Dec 31, 2023 | 2y |
| Contrarius Investment Management Ltd | DO Diamond Offshore Drilling, Inc. | 13G/A | 1.9% | Dec 31, 2023 | 2y |